LivaNova PLC

NASDAQ:LIVNUnited States

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. It includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Contact Information

Headquarters

20 Eastbourne TerraceLONDON, United Kingdom W2 6LG

Phone

203-325-0662

Fax

---

Executives

Independent Chairman of the Board

William Kozy

Chief Executive Officer, Director

Vladimir Makatsaria

Chief Financial Officer

Alex Shvartsburg

President, Global Epilepsy

Stephanie Bolton

Senior Vice President, Chief Legal Officer, Corporate Secretary

Michael Hutchinson